Mayne Pharma provides update on Womens Health pipeline
Filed with ASX · · 2 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- 2020 Full Year Investor Presentation
- 2020 Full Year Media Release
- Mayne Pharma announces strategic partnership with Novast
- MYX announces FDA filing acceptance of E4/DRSP in the US
- S&P DJI Announces June 2020 Quarterly Rebalance
Later from Mayne Pharma
- Chairman and CEOs Addresses to Shareholders
- 2021 Half Year Media Release
- 2021 Half Year Investor Presentation
- FDA approval of novel oral contraceptive NEXTSTELLIS
- Class action proceeding
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma